You have successfully sign out
Loading...
Biohaven Ltd.
BHVN
Company Description
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Â
NYSE
Unprofitable
Unprofitable
15.71USD
1.48Â ( 10.40%)Market Closed (as of Aug 15, 20:00 EDT)
Relative Strenght
2
Volume Buzz
41%
Earning Acce
No
Dist 52w H.
72%
